**Executive Summary**
The Pharmaceutical and Medical Devices Promotion and Development Scheme (PMPDS) aims to foster the growth of the pharmaceutical and medical device sectors through various promotional activities. Since FY2021-22, the Department of Pharmaceuticals has supported numerous studies, evaluations, and events. The provided document details the financial allocations and disbursements for these activities, including mega events, up to the fiscal year 2025-26.
**Key Points / Main Content**
**Scheme Objectives and Activities**
* The PMPDS aims to facilitate the growth and development of the pharmaceutical sector through study reports, awareness programs, database creation, and industry promotion.
* Since FY2021-22, the Department has conducted 25 studies/evaluations and organized/supported 65 events (workshops, seminars, webinars).
* These activities are conducted with academic institutions, government bodies, industry associations, non-profit organizations, and private companies.
* Seminars and workshops are held nationwide, including in Andhra Pradesh, and are open to participants from the pharmaceutical and medical sectors.
**Financial Support and Events**
* Annexure-I details the amounts sanctioned and disbursed for studies and events from 2021-22 to 2025-26.
* Sanctioned amounts range from ₹2.00 lakh in 2021-22 to ₹4.83 lakh in 2025-26.
* Disbursed amounts range from ₹1.20 lakh in 2021-22 to ₹1.80 lakh in 2025-26.
* Annexure-II shows the number of supported seminars, conferences, workshops, conventions, and exhibitions: 3 in 2022-23, 11 in 2023-24, and 14 in 2024-25.
* Annexure-III provides details of mega events, including India Pharma and India Medical Device meets.
* Mega events have involved significant expenditure, such as ₹85.80 lakh for India Pharma and India Medical Device 2022 and ₹815.10 lakh for India MedTech Expo 2023.
* These events aim to strengthen dialogue, promote domestic manufacturing, foster innovation, and position India as a global hub for pharmaceuticals and medical devices.
* The Department has also provided non-financial logo support to 20 events for Pharma and Medical Device sectors since 2021-22.
**Impact Analysis**
**Pharmaceutical and Medical Device Industry**
* **Impact:** The industry benefits from promotional activities, enhanced dialogue with the government, increased focus on innovation and domestic manufacturing, and opportunities for business partnerships.
* **Action Required:** Participation in organized events, workshops, and seminars to leverage knowledge sharing and networking opportunities.
**Academic Institutions and Government Autonomous Bodies**
* **Impact:** These entities are involved in conducting studies, evaluations, and organizing events, contributing to sector development and knowledge dissemination.
* **Action Required:** Continued collaboration with the Department of Pharmaceuticals in conducting research and hosting promotional activities.
**Industry Associations, Non-profit Companies, and Private Companies**
* **Impact:** These stakeholders receive support for organizing events and gain opportunities to promote their products and services, collaborate, and stay abreast of industry trends.
* **Action Required:** Engagement with the Department of Pharmaceuticals for event support, participation in scheme-related activities, and adherence to scheme guidelines.
Key Entities Referenced
Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS): The primary scheme discussed, aimed at facilitating growth and development in the pharmaceutical and medical devices sectors.
Department of Pharmaceuticals: The government department responsible for implementing and supporting the PMPDS.
India Pharma and India Medical Device meets: Key mega events organized under PMPDS to promote the pharmaceutical and medical device industries.
Ministry of Chemicals and Fertilizers: The overarching ministry under which the Department of Pharmaceuticals operates.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
Pharmaceutical & Medical Devices Promotion
and Development Scheme
Posted On: 13 MAR 2026 3:48PM by PIB Delhi
Pharmaceutical and Medical Devices Promotion and Development Scheme (PMPDS) aims to facilitate
growth and development of pharmaceutical sector through study/survey reports, awareness programs,
creation of databases and promotion of industry.
Since FY2021-22, Department has conducted 25 studies and evaluations on topics of importance to the
Department and has organized/supported 65 events/workshops/seminars/webinars across the country to
sensitize the pharmaceutical and medical devices industry on various topics through academic institutions,
government autonomous bodies, firms empanelled with Government of India, National/State level
industry associations, non-profit companies/organization in pharmaceutical & medical devices sector,
private companies of good repute and Government agencies.
Seminars/workshops conducted under the scheme are organised at various locations across the country
including Andhra Pradesh and are open to participants from the pharmaceutical and medical sectors
nationwide.
The total amount sanctioned and disbursed under PMPDS year-wise is given at Annexure-I. The number
of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance
under PMPDS during the last three years is given at Annexure-II.
The details of mega events organised under PMPDS including India Pharma and India Medical Device
meets, locations, participation from different states, total expenditure incurred including Grant-in-Aid
under the PMPDS and outcomes achieved are at Annexure-III.
Department of Pharmaceuticals has supported 20 events with non-financial logo support under PMPDS
since 2021-22. The non-financial logo support is provided to various organizations for Pharma and
Medical Device events in compliance with the scheme guidelines.
Annexure I
Details of amount sanctioned and disbursed for preparing various study reports and organizing various
seminars, conferences, conventions, workshop and exhibitions under PMPDS during last five years.
S. Item 2021-22 2022-23 2023-24 2024-25 2025-26
No.
(as on
12.3.2026)
1. Amount sanctioned (₹ in 2.00 3.00 7.00 4.00 4.83
lakh) for studies and events2. Amount Disbursed (₹ in lakh) 1.20 0.81 2.77 2.02 1.80
for studies and events
Annexure II
Details of number of seminars, conferences, workshops, conventions and exhibitions supported with
financial assistance under PMPDS during the last three years
S. No. Item 2022-23 2023-24 2024-25
1. No. of seminars, conferences, workshops, 3 11 14
conventions and exhibitions supported with
financial assistance
Annexure III
Details of mega events organised under PMPDS including India Pharma and India Medical Device meets,
their locations, participating states, total expenditure incurred including Grant-in-Aid under the PMPDS
and outcomes achieved.S. Name Date of Location(s) Participating Total Key Outcomes
No of Mega event States Expenditure Achieved
Event incurred
(₹ in lakh)
1. India 25.2.2021 FICCI, Maharashtra, 18.52 The India Pharma &
Pharma to Federation Karnataka, India Medical Devices
and 26.2.2021 House, New Gujarat, 2021 Conference
India Delhi Rajasthan, advanced dialogue
and
Medical Delhi, between government
Device 1.3.2021 Haryana, and industry on policy
2021 to Madhya priorities and sectoral
(Hybrid 2.3.2021 Pradesh, reforms. Key outcomes
Mode) Orissa, Goa, included emphasis on
Uttar Pradesh, strengthening domestic
Telangana, manufacturing,
Chhattisgarh, enhancing resilient
Kerala, supply chains,
Himachal promoting innovation
Pradesh, and R&D, improving
Uttarakhand, healthcare access, and
Punjab and supporting digital
Andhra health and advanced
Pradesh medical technologies to
through Andhra position India as a
Pradesh global hub for
MedTech Zone affordable medicines
(AMTZ) and medical device
manufacturing.
Maharashtra,
Karnataka,
Gujarat,
Rajasthan,
Delhi,
Haryana,
Madhya
Pradesh,
Orissa, Goa,
Uttar Pradesh,
Telangana,
Chhattisgarh,
Kerala,
Himachal
Pradesh,
Uttarakhand,
Punjab andS. Name Date of Location(s) Participating Total Key Outcomes
No of Mega event States Expenditure Achieved
Event incurred
(₹ in lakh)
Andhra
2. India 25.4.2022 Dr. 85.80 The India Pharma
Pradesh
Pharma to Ambedkar 2022 and India
through Andhra
and 27.4.2022 International Medical Device 2022
Pradesh
India Centre, New Conferences led to key
MedTech Zone
Medical Delhi outcomes including
(AMTZ)
Device strengthened dialogue
2022 between government
and industry on policy
support and ease of
doing business,
promotion of domestic
manufacturing and
resilient supply chains,
and greater focus on
innovation, digital
health, and advanced
medical technologies.
The deliberations also
emphasized regulatory
collaboration, value-
based healthcare, and
enhanced investments
through industrial
clusters and medical
device parks to position
India as a global hub
for pharmaceuticals
and medical devices.S. Name Date of Location(s) Participating Total Key Outcomes
No of Mega event States Expenditure Achieved
Event incurred
(₹ in lakh)
3. India 26.5.2023 Hotel Ashok, 113.73 The 8th Edition of
Pharma to New Delhi India Pharma &
and 27.5.2023 India Medical Devices
India 2023 strengthened
Medical collaboration among
Device government, regulators,
2023 industry, and academia
to advance domestic
manufacturing,
innovation, and global
competitiveness. Key
outcomes included
emphasis on scaling
MedTech innovations
to large-scale
manufacturing,
strengthening quality
and R&D capabilities,
promoting digital
transformation and
biosimilars in
pharmaceuticals, and
fostering industry–
academia partnerships
to support sustainable
growth of India’s
healthcare ecosystem.S. Name Date of Location(s) Participating Total Key Outcomes
No of Mega event States Expenditure Achieved
Event incurred
(₹ in lakh)
4. India 17.8.2023 Gandhinagar, 815.10 The India MedTech
Medtech to Gujarat Expo 2023 showcased
Expo 19.8.2023 India’s growing
2023 capabilities in the
medical devices sector
and strengthened
engagement among
policymakers, industry,
start-ups, academia,
and international
stakeholders. Key
outcomes included
promotion of
indigenous innovations
and start-ups,
facilitation of global
business partnerships
through buyer–seller
meetings, identification
of investment
opportunities, and
enhanced collaboration
in R&D, skill
development, and
advanced healthcare
technologies,
reinforcing India’s
position as an emerging
hub for medical device
manufacturing and
innovation.
This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a
written reply in the Lok Sabha today.
*****
PC/PM
(Release ID: 2239578) Visitor Counter : 133
Read this release in: Urdu , ही